Literature DB >> 19162242

Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice.

Fukumi Furukawa1, Takashi Yoshimasu, Yuki Yamamoto, Nobuo Kanazawa, Takao Tachibana.   

Abstract

It is likely that mast cell and histamine metabolism are involved in autoimmune tissue injury such as cutaneous lupus erythematosus (LE) because different histamine receptors can regulate Th1 and Th2 cells. In order to verify the role of the axis of mast cell-histamine metabolism-histamine receptor, the autoimmune mouse has been investigated. The MRL/Mp-lpr/lpr (MRL/lpr) mouse is a good model for the spontaneous development of skin lesions similar to those seen in human LE. In skin lesions from MRL/l mice, there are many infiltrating T cells and mast cells in the dermis and impaired histamine metabolism, in which the low activity of histamine-N-methyltransferase and the related prolonged effects of histamine in the skin tissue seem to play a definite pathological role in the development of spontaneous lupus-like eruptions. The expression of H2R on the mast cell decreases within these skin lesions at 5 months of age. It is interesting that the activity of HMT runs in parallel with the expression of H2R over the time course of the skin changes in MRL/l mice, but the relationship between these two observations remains obscure. The accumulation of mast cells expressing H2R and prolonged effects of histamine may occur to regulate the production of Th1 and Th2 cytokines in the skin lesions of MRL/l mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162242     DOI: 10.1016/j.autrev.2008.12.016

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Authors:  Lisa G Rider; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2010-09

2.  Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.

Authors:  K A Nikolova-Ganeva; V V Gesheva; T A Todorov; R E Voll; T L Vassilev
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

Review 3.  Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective.

Authors:  Dmitri Gourevitch; Andrew V Kossenkov; Yong Zhang; Lise Clark; Celia Chang; Louise C Showe; Ellen Heber-Katz
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-09-01       Impact factor: 4.730

Review 4.  Mast cell mediators in tolerance.

Authors:  Victor C de Vries; Randolph J Noelle
Journal:  Curr Opin Immunol       Date:  2010-09-29       Impact factor: 7.486

5.  Mapping Novel Subcutaneous Angiogenesis Quantitative Trait Loci in [B6×MRL]F2 Mice.

Authors:  Krista Morales; Leahana Rowehl; Jason Smith; Rich Cole; Fang Liu; Barb Beyer; Bruce J Herron
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-09-01       Impact factor: 4.730

Review 6.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

7.  Genome-Wide Association Studies Identify Candidate Genes for Coat Color and Mohair Traits in the Iranian Markhoz Goat.

Authors:  Anahit Nazari-Ghadikolaei; Hassan Mehrabani-Yeganeh; Seyed R Miarei-Aashtiani; Elizabeth A Staiger; Amir Rashidi; Heather J Huson
Journal:  Front Genet       Date:  2018-04-04       Impact factor: 4.599

8.  The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL/lpr mice.

Authors:  Naoya Mikita; Nobuo Kanazawa; Takashi Yoshimasu; Takaharu Ikeda; Hong-Jin Li; Yuki Yamamoto; Fukumi Furukawa
Journal:  Clin Dev Immunol       Date:  2009-04-26

9.  Histamine 50-skin-prick test: a tool to diagnose histamine intolerance.

Authors:  Lukas Kofler; Hanno Ulmer; Heinz Kofler
Journal:  ISRN Allergy       Date:  2011-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.